LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

Search

Teleflex Inc

Gesloten

SectorGezondheidszorg

103.7 -0.56

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

102.91

Max

106.09

Belangrijke statistieken

By Trading Economics

Inkomsten

-531M

-409M

Verkoop

132M

913M

K/W

Sectorgemiddelde

28.636

121.746

Dividendrendement

1.25

Winstmarge

-44.785

Werknemers

14,100

EBITDA

-546M

-323M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+22.56% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

1.25%

2.26%

Volgende Winsten

26 feb 2026

Volgende dividenddatum

16 mrt 2026

Volgende Ex Dividend datum

6 mrt 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-735M

4.7B

Vorige openingsprijs

104.26

Vorige sluitingsprijs

103.7

Nieuwssentiment

By Acuity

50%

50%

160 / 352 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

Teleflex Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

12 feb 2026, 23:57 UTC

Populaire aandelen

Stocks to Watch: Applied Materials, Arista, DraftKings, Pinterest

12 feb 2026, 23:35 UTC

Winsten
Belangrijke Marktbewegers

Arista Networks Surges on AI Networking Demand, Despite Rising Costs

12 feb 2026, 23:28 UTC

Winsten

Applied Materials Profit Rises on Soaring AI Demand -- Update

12 feb 2026, 21:47 UTC

Winsten

Vertex Pharmaceuticals Revenue Climbs on Continued Cystic Fibrosis Demand

13 feb 2026, 00:00 UTC

Marktinformatie

ANZ Gets a New Bull as Productivity Prospects Improve -- Market Talk

12 feb 2026, 23:47 UTC

Marktinformatie

Nikkei May Fall After AI Concerns Drag Stocks on Wall Street -- Market Talk

12 feb 2026, 23:38 UTC

Marktinformatie

Gold Steady; Could Undergo Technical Recovery -- Market Talk

12 feb 2026, 23:33 UTC

Winsten

Coinbase Swings to a Fourth-Quarter Loss Amid Crypto Meltdown -- 2nd Update

12 feb 2026, 23:09 UTC

Marktinformatie

South32's Hermosa Review Stokes Spending Fears -- Market Talk

12 feb 2026, 22:55 UTC

Winsten
Populaire aandelen

Applied Materials, DraftKings, Airbnb: Earnings in Focus -- WSJ

12 feb 2026, 22:46 UTC

Marktinformatie

Northern Star Outlook Needs Project Done On Time, In Budget -- Market Talk

12 feb 2026, 22:23 UTC

Winsten

Coinbase Swings to a Fourth-Quarter Loss Amid Crypto Meltdown -- Update

12 feb 2026, 22:15 UTC

Winsten

Agnico-Eagle Mines: Gold Production for 2026 and 2027, Expected at 3.3M to 3.5M Ounces Annually, Is Consistent With Previous Guidance, With Offsetting Adjustments Between Mine Sites >AEM.T

12 feb 2026, 22:15 UTC

Winsten

Agnico-Eagle Mines Raises Dividend to 45c >AEM.T

12 feb 2026, 22:15 UTC

Winsten

Agnico-Eagle Mines 4Q Rev $3.56B >AEM.T

12 feb 2026, 22:15 UTC

Winsten

Agnico-Eagle Mines 4Q EPS $3.04 >AEM.T

12 feb 2026, 22:00 UTC

Winsten

AGNICO EAGLE REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - RECORD QUARTERLY AND ANNUAL FREE CASH FLOW; 2025 PRODUCTION GUIDANCE ACHIEVED; TOTAL 2025 SHAREHOLDER RETURNS OF $1.4 BILLION; DIVIDEND INCREASED BY 12.5%; UPDATED THREE-YEAR GUIDANCE >AEM.T

12 feb 2026, 22:00 UTC

Winsten

Agnico-Eagle Mines 4Q Rev $3.56B >AEM

12 feb 2026, 22:00 UTC

Winsten

Agnico-Eagle Mines 4Q Net $1.52B >AEM

12 feb 2026, 22:00 UTC

Winsten

Agnico-Eagle Mines 4Q Adj EPS $2.70 >AEM

12 feb 2026, 22:00 UTC

Winsten

AGNICO EAGLE REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - RECORD QUARTERLY AND ANNUAL FREE CASH FLOW; 2025 PRODUCTION GUIDANCE ACHIEVED; TOTAL 2025 SHAREHOLDER RETURNS OF $1.4 BILLION; DIVIDEND INCREASED BY 12.5%; UPDATED THREE-YEAR GUIDANCE >AEM.T

12 feb 2026, 22:00 UTC

Winsten

Agnico-Eagle Mines 4Q EPS $3.04 >AEM

12 feb 2026, 21:57 UTC

Winsten

XP 4Q Rev BRL4.95B >XP

12 feb 2026, 21:52 UTC

Winsten

Coinbase Revenue Falls Short as Crypto Market Sags -- Barrons.com

12 feb 2026, 21:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

12 feb 2026, 21:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

12 feb 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

12 feb 2026, 21:47 UTC

Winsten

Morningstar 4Q Rev $641M >MORN

12 feb 2026, 21:39 UTC

Winsten

Coinbase Revenue Falls Short as Crypto Market Sags -- Barrons.com

12 feb 2026, 21:38 UTC

Winsten

Howmet Stock Jumps. Earnings Show Strength For This Sector. -- Barrons.com

Peer Vergelijking

Prijswijziging

Teleflex Inc Prognose

Koersdoel

By TipRanks

22.56% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 130.17 USD  22.56%

Hoogste 155 USD

Laagste 115 USD

Gebaseerd op 7 Wall Street-analisten die 12-maands prijsdoelen bieden voor Teleflex Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

7 ratings

2

Buy

4

Hold

1

Sell

Technische score

By Trading Central

122.73 / 135.75Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Gemiddeld Termijn

Bullish Evidence

Lange Termijn

No Evidence

Sentiment

By Acuity

160 / 352 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Teleflex Inc

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
help-icon Live chat